Stay updated on Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    New sections How to Read a Study Record, Common Questions, and How to Join a Study were added. The page now shows recruitment status as No longer looking for participants and the revision label updated to v3.6.0, with a formatting change from Intervention / Treatment to Intervention/Treatment.
    Difference
    0.5%
    Check dated 2026-06-14T05:18:19.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Enrollment-related status updates are now shown for the study, including an Enrollment issue and a Terminated designation with corresponding dates. These changes reflect shifts in recruitment status and the overall study activity.
    Difference
    0.5%
    Check dated 2026-06-07T00:12:51.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now displays revision v3.5.4, replacing the previous v3.5.3. This represents a minor update to the page's revision history and does not alter the study details.
    Difference
    0.1%
    Check dated 2026-05-16T10:08:31.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page’s footer revision label was updated from **v3.5.2** to **v3.5.3**, reflecting a website software/version change rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-04-25T06:03:02.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T03:49:46.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    Added revision: v3.5.0 and removed revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T04:26:15.000Z thumbnail image

Stay in the know with updates to Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page.